NEXTCURE INC
NXTC · NASDAQ
Updated at 2026-10-14 09:27:48
- Today's High
- $6.80
- Today’s Low
- $6.21
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $7.08
- Previous Close
- $6.64
- Volume
- 130.47K
- Market Cap
- $30.39M
- P/E Ratio
- --
- EPS
- $-10.26
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 2850 QUARRY LAKE DRIVE, BALTIMORE, MD, UNITED STATES, 21209
- Country
- US
- Listing Date
- 2019-05-09
- Fiscal Year End
- December
- Shares Outstanding
- 4.07M
- CIK
- 0001661059
- Website
- www.nextcure.com
NextCure, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of novel immunomedicines to treat cancer and other diseases related to the immune system by restoring normal immune function. The company is headquartered in Beltsville, Maryland.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$15.09M
2026-03-31
$9.82M
2025-12-31
$9.75M
2025-09-30
$8.94M
Net Income
2026-06-30
-$14.89M
2026-03-31
-$9.79M
2025-12-31
-$9.43M
2025-09-30
-$8.62M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-1.84
2026-03-31
$-1.87
2025-12-31
$-0.81
2025-09-30
$-3.22
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$14.62M
2026-03-31
-$9.51M
2025-12-31
-$9.07M
2025-09-30
-$8.09M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $15.09M | $9.82M | $9.75M | $8.94M |
| Net Income | -$14.89M | -$9.79M | -$9.43M | -$8.62M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-1.84 | $-1.87 | $-0.81 | $-3.22 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$14.62M | -$9.51M | -$9.07M | -$8.09M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.